Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: Stimulus for a GABA hypothesis of autism

Medical Science Monitor

Volumn 8, Issue 8, 2002, Pages

  Dhossche, Dirk ^a   Applegate, Heather ^a   Abraham, Ann ^a   Maertens, Paul ^a   Bland, Lorna ^a   Bencsath, Aladar ^a   Martinez, José ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

ADHD; Autistic disorders; Catatonia; GABA; Mood disorders; Plasma levels; Seizure disorders

Indexed keywords

4 AMINOBUTYRIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BIOCHEMICAL MARKER; CENTRAL STIMULANT AGENT; CITALOPRAM; CLONIDINE; DEXAMPHETAMINE; FLUOXETINE; GUANFACINE; LAMOTRIGINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; THIORIDAZINE; VALPROIC ACID; BIOLOGICAL MARKER;

ADOLESCENT; AFFECTIVE NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CATATONIA; CHILD; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; FEMALE; GABAERGIC SYSTEM; GAS CHROMATOGRAPHY; HUMAN; HYPOTHESIS; MALE; MASS SPECTROMETRY; OUTPATIENT; SEIZURE; BLOOD; PILOT STUDY; PRESCHOOL CHILD;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; GAMMA-AMINOBUTYRIC ACID; HUMAN; PILOT PROJECTS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036691555     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Syndromes of autism and atypical development
2. Autism
3. Neurobiology ofantism
4. Elavated levels of plasma and urine gamma-aminobutyric acid: A case study of an autistic child
5. Suppressed GABAergic inhibition as a common factor in suspected ethiologies of autism
6. Serotonin and amino acid components in platelets of autistic children
7. Pervasive developmental diorders and GABAergic system in patients with inverted duplicated chromosome 15
8. Plasma GABA in children and adolescent with mood, behaviour and comorbid mood and behavioral disorders: A preliminary study
9. Divalproex sodium increases plasma GAVA levels in healthy volunteers
10. Plasma GABA levels in neurological patients under treatment with valproic acid
11. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment
12. Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs
13. Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal
14. Plasma and CSF GABA in effective illness
15. Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders
16. Assessment of GABA concentration in human brain using two dimensional proton magnetic resonance spectroscopy
17. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study
18. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by magnetic resonance spectroscopy
19. Reductions in occipital cortex GABA levels in panic disorder detected with magnetic resonance spectroscopy
20. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression
21. Reelin gene alleles and haplotypes as a factor predisposing to antistic disorder
22. Dysregulation of reelin and Bcl-2 proteins in autistic cerebellum
23. Infantile autism and associated autosomal chromosome abnormalities: A register-based study and a literature survey
24. Linkage-disequilibrium mapping of autistic disorders, with 15q11-13 markers
25. Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder
26. Paradoxieal reactions elicited by diazepam in children with classic autism
27. The treatment of epilepsy in autism
28. Theoretical aspects of the study of benzodiazcpine receptors in inafntile autism
29. Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study
30. The incidence of siezure among children with autistic symptoms
31. Epilepsy in autism and autisticlike conditions
32. Infantile autism and effective disorder
33. Effective disorder in people with autism: A review of publisher cases
34. GABA and epileptiogenesis
35. Antiepileptic drugs: Effective use in autism spectrum disorders
36. GABA and mood disorders: A brief review and hipothesis
37. Low brain GABA level is associated with poor seizure control
38. Catatonia in autistic disorder: A sign of comorbity or variable expression
39. Catatonia in children and adolescents
40. Catatonia in Autistic Disorders (brief report)
41. Catatonia, autism, and ECT
42. Case series: Catatonic syndrome in young people
43. Catatonia in autistic spectrum disorders
44. Catatonia in an adolescent with Prader-Willi Syndrome
45. Decreased density of GABA-A receptors in the left sensorimotor cortex in a kinetic catatonia: Investigation in vivo benzodiazepine receptor binding
46. Treatment with lorazepam and electroconvulsive therapy
47. Adventures with GABA. Fifty years on
48. Development of GABAergic neurons and their transporter in human temporal cortex
49. Postnatal maturation of human GABAA receptors measured with positron emmision tomography
50. GABA signaling during development: New data and old questions
51. Neurotransmitters and neuromodulators during early human development
52. GABAergicinnervation organizes synaptic and extrasynaptic GABAA receptor clustering in cultured hippocampal neutrons
53. Hypoplasia of cerebral vermis lobules VI and VII in autism
54. Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study
55. Infantile autism and puberty
56. Outcome in autism and autistic-like symptom
57. Gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty
58. Neuropeptides, neurotransmitters, neurosteroids, and the onset of puberty